Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways.

已完结 10 由 000 发布于 2025/3/3 15:44:35

DOI:10.1136/ard-2024-226051
作者：Georgia-Savina Moysidou,?Panagiotis Garantziotis,?George Sentis,?Dimitra Nikoleri,?Nikolaos Malissovas,?Myrto Nikoloudaki,?Eirini-Maria Stergioti,?Styliani Polia,?Nikolaos Paschalidis,?Anastasia Filia
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Objectives: Belimumab is a putative disease-modifying agent in systemic lupus erythematosus (SLE), yet the molecular underpinnings of its effects and the ability to predict early clinical re

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NaturePerceptual and conceptual novelty independently guide infant looking behaviour: a systematic review and meta-analysis